Population Based Survey of Chronic Non-Communicable Diseases at Gilgel Gibe Field Research Center, Southwest Ethiopia by Muluneh, AT et al.






POPULATION BASED SURVEY OF CHRONIC NON-
COMMUNICABLE DISEASES AT GILGEL GIBE FIELD 




























BACKGROUND: Chronic Non-communicable Diseases are increasingly becoming more prevalent and 
burden to the health care system in developing countries including Ethiopia.  However, evidences 
showing the magnitude of the problem in those countries are scarce particularly in a community setting.  
The objective of this study was to determine the magnitude of chronic non communicable diseases in a 
community. 
METHODS: A population-based cross-sectional study was conducted in Gilgel Gibe Field Research 
Center from late September 2008 to end of January 2009.  A random sample of 4,469 individuals aged 
15-64 years was studied. Data on characteristics and chronic symptom inventories were collected by 
interviewing study participants. Blood pressure was taken three times from each individual and blood 
sugar and lipid levels were determined after an overnight fasting.  Data were analyzed using SPSS for 
Windows version 16.0 and STATA 11. 
RESULTS: The overall prevalence of CNCD was 8.9% (7.8% men and 9.8% women). The specific 
observed prevalence were 0.5% for diabetes mellitus (DM), 2.6% for hypertension, 3.0% for 
cardiovascular diseases, 1.5% for asthma and 2.7% for mental illness.  In addition 3.1% and 9.3% of 
the study population had been informed to have DM and hypertension respectively.   
CONCLUSION: There is a high prevalence of CNCD among the study population indicating an 
immediate need for preventive action and also warrant further nationally representative study. 
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INTRODUCTION                                                                                                  
 
Chronic Non-communicable Diseases (CNCDs) 
are by their nature lifelong or a condition as one of 
3 months’ duration or longer (1); most with long 
term complications resulting in disabilities 
affecting the quality of life and creating pressure 
on the health care systems. Because of the 
requirement for life long treatment and care, the 
cost implication on health sector is huge 
signifying the importance of determining the 
burden to plan prevention strategies. CNCDs 
include Diabetes mellitus, Cardiovascular 
diseases, (Rheumatic heart disease, Coronary heart 
disease), Cerebro-vascular disease (stroke), 
Mental illnesses (Schizophrenia, Bipolar, 
Depression), Neurologic disorders (Epilepsy, 
Dementias), Respiratory diseases (Asthma and 
COPD), Digestive System diseases, Congenital 
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The priority of health care in developing countries 
focuses on communicable diseases which are 
proportionally important than CNCDs. Though 
CNCDs are believed to be problem of affluent 
societies, in reality they represent an under 
reported and neglected burden on health in the 
developing countries and one that is ever-
increasing (8). In absolute numbers, deaths from 
CNCDs are higher in sub-Saharan Africa than the 
other regions in the world (9).  CNCDs are 
projected to be the leading cause of death in all 
income groups in 2015 (3).  
There are proven preventive strategies for 
CNCDs. These measures would significantly 
prevent disease and delay complications that 
would otherwise demand costly and lifelong 
medical care. On the other hand, if the emergence 
and prevention of risk factors remain unintervened 
and the health services left undirected, the 
problem can increasingly cause more human 
suffering and escalate the cost of treatment (10).  
In Ethiopia, declining mortality rates, rising 
life expectancy and increasing urbanization have 
been observed (11,12,13). As a result, Ethiopia is 
likely to be in a transition period with respect to 
the epidemiology of CNCDs (14). The few 
existing reports in Ethiopia are health facility 
based (15, 16) which do not show the magnitude 
of CNCDs at community level. Very limited 
community based studies tried to show the 
magnitude of the problem on specific diseases 
(17). Due to lack of data showing the real burden 
of CNCDs in the developing world in general and 
in Ethiopia in particular, there is no clear ground 
and guidance for policy makers to plan and 
implement intervention strategies.  
Therefore, this study was conducted to 
determine the magnitude of CNCDs in a 
community setting to be a basis for decision 
making and policy formulations. Moreover, this 
study will serve as baseline information for further 
studies at national level.    
 
SUBJECTS, MATERIALS AND METHODS  
 
The study was conducted in Gilgel Gibe Field 
Research Center (GGFRC) of Jimma University 
(JU). The center serves as health and 
demographic surveillance system for the 
University and comprises of 8 rural and two 
urban kebeles (the lowest administrative unit in 
Ethiopia).  
The study base was mapped, houses 
numbered and census carried out in August 2005. 
Since then, there is an ongoing demographic and 
health surveillance in the center. The study area 
comprised of about 11,000 households with a total 
population of 50,000 in the center. Out of the total 
population, age range of 15 to 64 years comprised 
of about 49%.  
Majority of the residents live with 
subsistence agriculture producing mainly food 
crops. There were one health center, two health 
stations and 4 health posts in the center during the 
study period. There were two trained health 
extension workers in each kebele. In the urban 
kebeles the source of water was either shallow dug 
well, pipe water or protected springs whereas the 
major sources of water in rural kebeles were 
unprotected. All rural kebeles were accessible 
only during dry season by four-wheel drive. All 
the kebeles had access to mobile phone and in 
addition the urban kebeles had access to home 
phone. 
This population-based cross-sectional study 
was conducted from September 2008 to January 
2009. Individuals’ age 15 to 64 years of both sex, 
who were residents of the 10 kebeles of the center 
were studied. The sample size was determined 
based on the WHO STEPS guideline stratifying 
the population by sex, age and residence (18). For 
both sexes, 250 individuals were taken from each 
age stratum giving a sample size of 2500.  
However, due to further stratification of the study 
population into urban and rural within age and 
sex, the sample size was doubled to 5,000. Taking 
10% non-response rate, the total sample size 
became 5,500 (Table 1).  
 
Table 1: Age and sex strata of study population, 





Total Male Female 
15-24 500 500 1000 
25-34 500 500 1000 
35-44 500 500 1000 
45-54 500 500 1000 
55-64 500 500 1000 
Total 2500 2500 5000 
Adding 10% for non-response 5500 




To select the study participants, the 2008 updated 
census list of the population and households of the 
ten kebeles was used as sampling frame. Taking 
25% urban and 75% rural population distribution 
in the center, the total sample was distributed 
proportionally. Then the sample was distributed to 
each kebele proportional to their population size. 
Using the age and sex stratified sampling frame 
obtained from the census list, individuals were 
selected randomly.  
Blood samples for hematological and 
biochemical values determination was collected 
from 60% (3,300) of randomly selected 
(conditional probability sampling) individuals 
from the total sample as per the recommendation 
of WHO (18). 
Interviewer administered structured 
questionnaires in English language were adapted 
from WHO STEPS instruments to collect data 
(18). All study instruments were translated into 
local languages (Amharic and Afaan Oromo) by 
native speakers and then back translated to 
English by two other competent persons. The 
questionnaires comprised of: socioeconomic and 
demographic variables, risk factors, and symptoms 
and history of CNCDs. Formats adapted from 
WHO STEPS guidelines were also used to 
measure blood pressure (BP), pulse rate, weight, 
height, waist and hip circumference, and 
biochemical markers such as fasting blood sugar 
level, total cholesterol and triglycerides values 
(18). 
Field personnel had a minimum of high 
school completion and competent in Amharic and 
Oromifa languages. Fifteen interviewers, six 
physical measurement recorders and 3 supervisors 
were recruited for CNCDs survey. Two nurses and 
2 laboratory technicians were recruited to collect 
blood samples. Training was given for data 
collectors and supervisors on the purpose of the 
study, how to get informed consent, on 
interviewing technique, physical measurements 
and recording data. Supervisors were additionally 
trained on supervision techniques. Blood sample 
collectors were also trained on obtaining informed 
consent, blood sample collection, blood sugar 
level measurement, and blood sample 
transportation and storage. Different training 
methods were employed, including interviewing 
practice and role playing. All data collectors were 
provided with manuals that covers the standard 
survey procedures and measurements.  
Pre-test was conducted on the interview and 
measurement sections of the study instrument in 
urban and rural settings which are physically away 
from the study area. After the pre-test, data 
collectors, supervisors and investigators discussed 
on experiences and identified gaps. Re-training 
was conducted with a focus on resolving 
problematic issues and then study instruments 
were finalized.  
Face to face interview was conducted at 
home level after the interviewers explained the 
purpose of the study and obtained the participant’s 
signed consent to participate in the study. Eligible 
respondents were declared unavailable if they 
were not found on three separate visits.  After 
completion of face to face interview, all 
respondents were given appointment for physical 
measurements. Additionally those respondents 
who were selected for biochemical tests were 
given instructions for overnight fasting (not to eat 
or drink after 8:00 pm) and early morning 
appointment given. Whole venous blood sample 
was collected in the morning (8:00am to 12:00 
noon) after cleaning the cubital area by 70% 
alcohol and stored in 3 ml vacutainer tubes. Then 
the sample was placed in ice-box and transported 
to the JUSH laboratory where the laboratory 
procedures are performed. Fasting blood glucose 
was determined on site immediately after sample 
collection using Glucometer (Sensocard, 
Hungary). Individuals with high blood pressure, 
with FBS level above 126mg/dl and other serious 
ailments were referred to health centers or Jimma 
University Hospital for better investigation and 
management.  Detail blood sample collection and 
laboratory processing methods are described in 
paper 4 & 5 of this special issue (Pages 41,52,53). 
Blood pressure apparatus was calibrated and 
standardized using mercury sphygmomanometer.  
Standardized and calibrated measuring 
instruments were used for physical measurements. 
Daily supervision was made in the field during 
data collection by field supervisors and 
investigators. Data collectors checked for data 
completeness and consistency before leaving each 
house. Field supervisors also checked the 
completeness and consistency of the data on daily 
basis and they returned to interviewers if the data 
were incomplete and inconsistent. Interviewers re- 





administered the questionnaire to the respondent under supervision by the 
supervisors.  
Data were double entered by trained data clerks using EpiDdata version 3.1. 
Incomplete and inconsistent data identified during data entry were returned to 
the data collectors for rectification. Moreover, data were checked for 
completeness, inconsistency and outliers by looking at their distribution. 
Incomplete and inconsistent data were excluded from the analysis.  Data were 
properly filed and stored both in electronic copies with back up and hard 
copies.  
Data were analyzed using SPSS for Windows version 16.0 and STATA 
11. Background of study participants, overall prevalence of CNCDs, reported 
prevalence of specific CNCDs and measured prevalence of specific CNCDs 
were determined. Frequencies and summary values were determined when 
appropriate. Overall prevalence of CNCDs was defined as the presence of any 
of the studied CNCDs on interview among the study population. Reported 
prevalence of specific CNCDs was defined as the presence of particular 
CNCDs among interviewed population diagnosed by health professionals while 
visiting health institutions; while observed/measured CNCDs was the presence 
of actual CNCDs on physical or biochemical measurement among measured 
population. 
The proposal was presented to Medical Sciences Faculty research 
committee for assuring scientific integrity and human subjects’ protection. The 
proposal was then submitted to the University’s Research and Publication 
Office for final ethical clearance and approval letter was obtained. Supportive 
letter was obtained from the university and given to the Jimma Zonal and to the 
four Woredas administrations.  Two written consent formats were developed 
and used: one for interview and physical measurements and the second one for 
blood sample collection. Preliminary finding was communicated to the local 
authorities and Jimma University community. 
 
Table 2 Interview response rate of study subjects by age sex and residence, GGFRC, Sept 2008- Jan 2009. 























Age in years          
15-24 
 
74 (15.1) 105(17.1) 179(16.2) 295(18.5) 284(16.0) 579(17.2) 369(17.7) 389(16.3) 758(17.0) 
25-34 
 
91(18.6) 121(19.7) 212(19.2) 295(18.5) 378(21.4) 673(20.0) 386(18.5) 499(20.9) 885(19.8) 
35-44 
 
113(23.1) 129(21.0) 242(21.9) 327(20.5) 372(21.0) 699(20.8) 440(21.1) 501(21.0) 941(21.1) 
45-54 
 
98(20.0) 126(20.5) 224(20.3) 323(20.3) 342(19.3) 665(19.8) 421(20.2) 468(19.6) 889(19.9) 
55 and above  114(23.3) 134(21.8) 248(22.4) 354(22.2) 394(22.3) 748(22.2) 468(22.5) 528(22.1) 996(22.3) 
          
Total 490(100.0) 615(100.0) 1,105(100.0) 1,594(100.0) 1,770(100.0) 3,364(100.0) 2,084(100.0) 2,385(100.0) 4,469(100.) 







 Of the planned sample size of 5,500 adults 
15-64 years of age for the face-to-face interview, 
4,469 (81.3%) were interviewed with male to 
female response rate of 75.8% and 86.7%. The 
response rate by age varies from 68.9% for 15-24 
years to 90.5% for those who are 55 years and 
above. The response rate was more or less similar 
by residence (Table 2).  
Background of study participants 
Of the 4469 respondents, 2385 were female 
(female to male ratio of 1.14), 22% in the age 
group of 55 years and above and nearly 25% of 
the respondents were from urban area. Of the 4363 
(2324 women, 2,039 men) respondents who 
reported about their educational status, 82% of the 
women and 60% of the men were unable to read 
and write. Out of 4446 study participants who 
reported about their occupation, 1949 (43.8%) 
were farmers (Table 3). Majority, 3994 (88.4%) of 
the 4440 individuals who reported their ethnic 
group were Oromo, whereas the remaining 
constituted Yem (4.5%), Amhara (3.2%) and 
Gurage (1.8%). 
 




 Men Women Total 
Socio-demographic variables № % № % № % 














































































Unable to read or write 
Able to Read & write only 
1-4 grade 
5-8 grade 



















































































































































Table 4: Reported prevalence of CNCDs by age, residence and sex, GGFRC, Sept 2008- Jan 2009. 
 
Variable Participant Prevalence 95% CI 
Overall Chronic Non-Communicable Diseases  
Male  2093 7.7 6.6 8.9 
Female 2267 9.9 8.7 11.2 
Urban 1082 16.4 14.2 18.7 
Rural 3278 6.4 5.6 7.3 
Total 4364 8.9 8.0 9.8 
Total – Told to have    
DM 4364 0.5 0.3 0.8 
HPN 4356 2.6 2.2 3.2 
Cardiac 4339 3.0 2.5 3.5 
Asthma 4331 1.5 1.1 1.9 
Epilepsy 4333 0.5 0.3 0.8 
Depression 4235 1.7 1.4 2.2 
Male – Told to have     
DM 2093 0.7 0.4 1.1 
HPN 2089 2.2 1.6 2.9 
Cardiac 2079 1.7 1.2 2.3 
Asthma 2077 1.5 1.0 2.1 
Epilepsy 2077 0.6 0.3 1.0 
Depression 2033 1.6 1.1 2.2 
Female – Told to have     
DM 2267 0.4 0.2 0.8 
HPN 2263 3.1 2.4 3.9 
Cardiac 2256 4.2 3.4 5.1 
Asthma 2250 1.5 1.0 2.1 
Epilepsy 2252 0.5 0.2 0.9 
Depression 2198 1.9 1.3 2.5 
Urban – Told to have     
DM 1082 1.1 0.6 1.9 
HPN 1081 5.8 4.5 7.4 
Cardiac 1077 5.7 4.4 7.2 
Asthma 1079 3.2 2.3 4.5 
Epilepsy 1079 0.7 0.3 1.5 
Depression 1046 2.4 1.6 3.5 
Rural – Told to have     
DM 3278 0.3 0.2 0.6 
HPN 3271 1.6 1.2 2.1 
Cardiac 3258 2.1 1.6 2.6 
Asthma 3248 0.9 0.6 1.3 
Epilepsy 3250 0.5 0.3 0.8 








Chronic Non-communicable diseases reported 
prevalence 
The overall prevalence of chronic non-
communicable disease was 8.9% (7.8% men and 
9.8% women). Of the 4364 respondents, 23 
(0.5%) reported that they were told to have 
diabetes mellitus by health professionals. The 
prevalence was 1.5% among urban and 0.4% for 
rural men and the corresponding values for urban 
and rural women were 0.8% and 0.2%, 
respectively. One hundred fifteen (2.6%) 
respondents, 4.6% of the urban men, 6.8% of the 
urban women, 1.5% of the rural men, 1.7% of the 
rural women reported that they were told by health 
professionals to have high blood pressure. Three 
percent of the total respondents, 2.7% of the urban 
men, 8.2% of the urban women, 1.2% of the rural 
men and 2.9% of the rural women reported as 
having CVD at the time of the interview. On the 
other hand, 1.5% reported to have been told as 
having asthma where the reported prevalence 
among urban men and women was 3.3% and 3.2% 
while for the rural men and women 1.0% and 
0.8%, respectively. The prevalence of epilepsy 
and mental illnesses was reported to be 0.5% and 
1.7%, respectively (Table 4).   
Fifty two (3.1%) of those tested had elevated 
blood glucose of more than 125mg/dl (≥7.0 
mmol/L) level and 301 (9.3%) had high blood 
pressure (SBP ≥ 140mmHg and/or DBP ≥ 90 
mmHg). Both the prevalence of  high blood sugar 
and high blood pressure showed increasing trend 
with age (p < 0.001), on the other hand raised 
blood pressure rate was significantly higher 
among urban residents (p < 0.001) (Table 5). 
Distribution of reported CNCDs by age is shown 
in table 6. 
 
Table 5: Observed/measured prevalence of DM and hypertension by age, residence and sex, GGFRC, Sept 


























































































Table 6: Prevalence of CNCDs by age, residence and sex, GGFRC, Sept 2008- Jan 2009. 
 










































































































































































Study participants reported as they are diagnosed by health professionals. 
 




Prevalence of cardiovascular diseases (p< 0.001), 
hypertension (p< 0.001), asthma (p< 0.001), 
diabetes mellitus (p=0.061) and overall CNCDs (< 
0.001) appeared to have an increasing trend with 




The main objective of this study was to describe 
the distribution of CNCDs by age, sex and 
residential areas. The response rate of the study 
was 81%.  The use of WHO STEPS methods and 
instruments that was standardized, population 
based nature of the study alongside with the use of 
random selection of study subjects and 
multidisciplinary composition of the research team 
are the strengths of this study. This study is one of 
the first of its kind in the country to undertake the 
three components of WHO STEPS (I, II, and III) 
(18) at community setting. Nevertheless, as the 
study has employed self-reporting as a proxy 
measure for the study of CNCDs, it is liable to 
self-report bias which can either underestimate or 
overestimate the prevalence of the diseases under 
study. The possible sources of bias could be 
problems in recall, misdiagnosis or misreporting. 
Underreporting could happen due to social 
desirability bias associated with stigma and 
discrimination especially in diseases like epilepsy 
and mental illnesses. Moreover, lack of equivalent 
local terminologies for different diseases, mainly 
mental illnesses, could also affect the estimate of 
the real prevalence of the problems. The finding of 
this result should be interpreted in light of these 
limitations.  
The overall reported prevalence of the 
CNCDs (Diabetes mellitus, hypertension, 
cardiovascular disease, Asthma, epilepsy, 
depression and mental illness) was found to be 
8.9%. The prevalence is higher in urban (16.4%) 
than in rural (6.4%) areas. This variation might be 
explained by urbanization associated with 
sedentarily lifestyle, lack of exercise and more 
stressful lifestyle. On the other hand, people living 
in urban area have better recognition of disease 
symptoms and better access to medical services 
compared to people living in rural areas. Thus, the 
prevalence of CNCDs in rural areas could be 
underestimated (19). The prevalence is higher 
among women (9.9%) as compared to men 
(7.7%). But this doesn’t hold true for each of the 
specific CNCDs as discussed below. As age 
increases the prevalence of CNCDs increases 




The prevalence of high blood pressure by 
self-report and physical measurement was 2.6% 
and 9.3 %, respectively. About four fold 
difference between the two measures indicates that 
a significant number of the population was not 
aware of their health status which calls for 
appropriate and timely intervention. The 
phenomenon called White Coat hypertension is 
less likely to attribute these big differences as the 
necessary procedures were followed during blood 
pressure measurement. Most individuals with high 
blood pressure do not have symptoms until 
complication arises to result in sudden death from 
heart attack or sudden intracranial bleeding or 
developed severe disability such as stroke as well 
heart failure. The observed prevalence of high 
blood pressure was more than two times higher in 
urban (17.0%) than rural (7.8%) areas. This 
finding is similar to finding of meta-analysis of 
studies in sub-Saharan countries (20) and 
Tanzania where prevalence of hypertension was 
observed to be higher in the urban compared with 
the rural population (21). High blood pressure was 
more prevalent among men (10.3%) than women 
(8.4%). This finding is in line with previous 
research report (20, 21). The pattern of increase 
with age was in the expected direction with 
marked increase in the age group 55 years and 
above (20.5%) (20). 
The prevalence of high blood pressure as 
obtained by physical measurement using blood 
pressure apparatus is higher than the findings in 
Ghana (22), Nigeria (23), and Lesotho (24). 
However, it is lower than the findings in 
Cameroon (25), and USA. Canada and Europe 
(26, 27). The findings were similar with the 
findings in rural Zulu (28). The possible reason is 




The reported prevalence of diabetes mellitus 
was 0.5% while the observed was 3.1% which is 
lower than the finding from Turkey where the 
crude prevalence of diabetes was 7.2% (previously 





undiagnosed, 2.3%) (19),   however, the 
proportion of undiagnosed DM is not comparable. 
As there is no age appropriate screening, many 
individuals with impaired glucose level might not 
be aware of their DM because of lack knowledge 
of symptoms and lack of information about the 
disease to seek treatment at the health care 
facilities. On the other hand, Type 2 DM may not 
manifest until blood glucose level is significantly 
raised compared to type one. These with Type 2 
DM might as a result be silent for many years until 
macro-vascular complication and micro-vascular 
complication arises.  It is therefore very important 
that early screening at the recommended age and 
appropriate intervention has to be implemented to 
avert the fatal and disabling complications. The 
urban prevalence (6.0%) is twice higher than the 
rural (2.9%). Urbanization could be the reason for 
the variation which is consistent with findings of 
other studies. Diabetes is more frequent among 
men (3.6%) than women (2.5%). Increasing trend 
of diabetes prevalence with age was observed and 
this is similar to another report (29).   
The prevalence of DM was much lower than 
the findings in Turkey, Canada and Greek (19, 30, 
31). This may be due to the fact that the screening 
of diabetes mellitus is offered at the age of 45 and 
then every five years for most developed countries 
and difference in life expectancy which might 
explain the higher prevalence of DM in developed 
countries (32, 33).   
The finding of this study is similar with 
finding in Brazilian study (34). This could be due 
to similarity in socio-demographic characteristics 
as both are developing countries. 
 
Cardiovascular Disease 
Self-reported CVD was 3.0%. Our 
observation in the areas of hypertension and 
diabetes mellitus above showed that self-reported 
prevalence of the two chronic illnesses was lower 
than the observed. This implies that the real 
magnitude of CVD could have been higher as both 
of these are risk factors to it. Only patients with 
full blown symptoms that are significant enough 
to affect individual’s daily activities and level of 
functioning might report their symptoms. This 
might result in a significantly lower prevalence of 
CVD.  On the other hand, there are neither 
sensitive nor specific questions used to determine 
the magnitude of cardiovascular disease. For 
example patients with chronic respiratory disease 
or anemia might be misclassified as CVDs which 
may overestimate the magnitude of the problems.   
 
Asthma 
Asthma had prevalence of 1.5% in the study 
population. However, the prevalence of asthma 
might have been underestimated as the symptoms 
are episodic, seasonal and diseases with less 
severe symptoms might not have been reported.  
However, reported prevalence of Asthma in this 
study area is similar with a study done in Jimma 
town and surrounding rural areas in Ethiopia (35).  
It is also similar with findings of study done in 
Estonia (36). 
 
Epilepsy and Mental Illness 
Epilepsy, depression and mental illnesses 
were also reported by 0.5%, 1.7%, and 0.7% of the 
study population, respectively. Reported 
prevalence of Epilepsy is similar with the study 
done in rural Tanzania (37) but lower than the 
finding of the study among the Zay society in 
Ethiopia and in Benin (38, 39). However, the 
actual magnitude of the problems in the study 
population could have been higher like that of 
hypertension and Diabetes Mellitus. Features of 
‘Tonic clonic’ seizures only might have been 
reported as other categories have subtle clinical 
features that are not recognized by the study 
participants or their health providers. On the other 
hand, epilepsy is one of a disease associated with 
witchcrafts and with ‘demonic possession’ in our 
community which might result in under reporting 
by the study participants.  
Mental illnesses on the other hand present a 
totally different challenge as they do not have 
litmus test like the others discussed which could 
lead to in under-reporting of the condition. 
Therefore the probability of reporting milder 
forms of mental illnesses could be less likely. 
Similar to epilepsy, mental illness have stigmata in 
our study community which further result in under 
reporting of these diseases. Therefore it would be 
very prudent to claim that they might be under 
reported 
In conclusion, this article reports one of the 
largest population-based studies ever conducted 
on the prevalence of CNCDs. High blood pressure 
was the commonest CNCD in the population 
followed by diabetes mellitus and CVD. High 




blood pressure and diabetes mellitus were more 
common among urban residents and men as 
compared to their counterparts. The pattern of 
occurrences for both diseases showed increasing 
trend with age. These findings clearly indicate that 
CNCDs require due emphasis in prioritizing for 
prevention and control. As this study revealed 
high magnitude of CNCDs in the study setting, 
conducting nationally representative multicenter 
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